Skip directly to page options Skip directly to A-Z link
Volume 13, Number 2—February 2007
Research

Meningococcal Disease in South Africa, 1999–2002

Garry B. Coulson*, Meningeal Disease Surveillance in South AfricaComments to Author , Mignon du Plessis*, Anthony M. Smith*, Linda de Gouveia*, Keith P. Klugman*†, Anne von Gottberg*Comments to Author , and for the Group for EntericRespiratoryGERMS-SA
Author affiliations: *National Institute for Communicable Diseases of the National Health Laboratory Service, Johannesburg, South Africa; †Emory University, Atlanta, Georgia, USA;

Main Article

Figure 4

Annual age-specific incidence rates for confirmed serogroup A, B, and Y meningococcal disease in South Africa, as reported from August 2001 through July 2002.

Figure 4. Annual age-specific incidence rates for confirmed serogroup A, B, and Y meningococcal disease in South Africa, as reported from August 2001 through July 2002.

Download

Main Article

1GERMS-SA: Sandeep Vasaikar (Eastern Cape); Nolan Janse van Rensberg, Peter Smith (Free State); Khatija Ahmed, Heather Crewe-Brown, Mike Dove, Charles Feldman, Alan Karstaedt, Olga Perovic, Pyu-Pyu Sein, Ruth Lekalakala (Gauteng); Wim Sturm (KwaZulu Natal); Ken Hamese (Limpopo); Keith Bauer (Mpumalanga); Denise Roditi, Rena Hoffmann, Lynne Liebowitz, John Simpson, Andrew Whitelaw (Western Cape); Adrian Brink (AMPATH); Claire Heney (Lancet); Martinus Senekal (PathCare).

Page created: June 29, 2010
Page updated: June 29, 2010
Page reviewed: June 29, 2010
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external